Oracle's Q2 FY2026 Earnings: Navigating AI Ambitions and Debt Concerns
Earnings Release and Conference Call Details:
Oracle is set to unveil its Q2 fiscal 2026 earnings after the US market closes on December 10th, followed by a conference call at 4:00 PM Central Time. Investors will be keen to hear management's insights and address key questions.
Q1 Success and Cloud Pipeline:
Oracle's Q1 results, announced in September, were a triumph. Despite revenue of $14.9 billion and adjusted EPS of $1.47 falling slightly short of analyst expectations, the company's cloud services pipeline took center stage. Remaining Performance Obligations (RPO) skyrocketed by 359% year-on-year to $455 billion, fueled by multi-billion-dollar contracts with key clients. This substantial backlog translates to significant future revenue potential.
Cloud Infrastructure (OCI) revenue soared 55% to $3.3 billion, while total cloud revenue climbed 28% to $7.2 billion. Oracle's forward guidance was equally impressive, predicting OCI revenue of $18 billion in fiscal 2026 (a 77% increase) and a staggering $144 billion by fiscal 2030.
The Debt Dilemma:
Despite the cloud success story, investor confidence has taken a hit since September. The primary concern revolves around Oracle's escalating debt levels. Free cash flow turned negative in fiscal Q4 2025, and the company is seeking an additional $38 billion in debt financing to fund AI infrastructure, on top of the $105 billion already outstanding as of August. Capital expenditure for fiscal 2026 is projected at a record $35 billion, significantly surpassing historical spending.
Credit markets are echoing caution. Oracle's five-year credit default swaps have risen to their highest since 2009, and rating agencies Moody's and S&P have issued negative outlooks, warning of potential leverage exceeding 4x debt-to-EBITDA by 2027-2028. A downgrade to non-investment grade status looms if debt accumulation outpaces earnings growth.
OpenAI Partnership and Concentration Risk:
Oracle's AI strategy hinges on its collaboration with OpenAI through the Stargate Project, a $500 billion endeavor. The company has secured a reported $300 billion, five-year contract with OpenAI, which could account for nearly one-third of Oracle's revenue by 2028. This high concentration creates significant counterparty risk.
Analysts question OpenAI's ability to meet its commitments, estimated at nearly $60 billion annually, despite its rapid growth. The project's complexity, involving multiple stakeholders, further adds to the challenge. Legal experts have also raised antitrust concerns regarding the collaboration among AI industry leaders.
Q2 Focus and Uncertainty:
For the December 10th earnings call, Wall Street anticipates adjusted EPS of $1.64 (+11% YoY) and revenue of approximately $16.2 billion (+15% YoY). Investors will scrutinize management's commentary, focusing on three crucial aspects:
- Will Oracle convert its substantial RPO backlog into recognized revenue?
- How will debt levels and capital expenditure be managed while maintaining investment-grade credit ratings?
- Can Oracle demonstrate tangible evidence of accelerated OCI growth beyond the OpenAI relationship?
Oracle's transformation into an AI infrastructure provider is a bold move. The coming weeks will reveal whether this strategy yields sustainable returns or if the company has overextended itself financially.
Divergent Analyst Perspectives:
Analyst opinions are divided, with 33 out of 46 analysts recommending a 'strong buy' or 'buy.' However, 13 analysts have issued 'hold' or 'sell' ratings, highlighting uncertainty. The average target price of $337 is significantly optimistic, despite recent downward revisions.
Technical Analysis and Support:
Oracle's share price has been on a rollercoaster. While it performed strongly in the first nine months of 2025, it has since declined by approximately 37% from its September peak, erasing most post-earnings gains.
The daily price chart exhibits a classic support pattern. After touching two significant support levels (the 200-day moving average and an ascending trendline since April), the share price has stabilized, generating a positive Moving Average Convergence Divergence (MACD) crossover.
A positive earnings surprise could propel Oracle's share price towards $250 near the 100-day moving average. Conversely, disappointing results and a breakdown below the 200-day moving average could lead to a retest of the $185 lows.
